These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 21621289

  • 1. Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience.
    Polistina FA, Guglielmi R, Baiocchi C, Francescon P, Scalchi P, Febbraro A, Costantin G, Ambrosino G.
    Radiother Oncol; 2011 May; 99(2):120-3. PubMed ID: 21621289
    [Abstract] [Full Text] [Related]

  • 2. Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.
    Gkika E, Hallauer L, Kirste S, Adebahr S, Bartl N, Neeff HP, Fritsch R, Brass V, Nestle U, Grosu AL, Brunner TB.
    BMC Cancer; 2017 Nov 21; 17(1):781. PubMed ID: 29162055
    [Abstract] [Full Text] [Related]

  • 3. Unresectable locally advanced pancreatic cancer: a multimodal treatment using neoadjuvant chemoradiotherapy (gemcitabine plus stereotactic radiosurgery) and subsequent surgical exploration.
    Polistina F, Costantin G, Casamassima F, Francescon P, Guglielmi R, Panizzoni G, Febbraro A, Ambrosino G.
    Ann Surg Oncol; 2010 Aug 21; 17(8):2092-101. PubMed ID: 20224860
    [Abstract] [Full Text] [Related]

  • 4. Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer.
    Mahadevan A, Jain S, Goldstein M, Miksad R, Pleskow D, Sawhney M, Brennan D, Callery M, Vollmer C.
    Int J Radiat Oncol Biol Phys; 2010 Nov 01; 78(3):735-42. PubMed ID: 20171803
    [Abstract] [Full Text] [Related]

  • 5. A pilot study of concurrent chemoradiotherapy with gemcitabine and cisplatin in patients with locally advanced biliary tract cancer.
    Lee KJ, Yi SW, Cha J, Seong J, Bang S, Song SY, Kim HM, Park SW.
    Cancer Chemother Pharmacol; 2016 Oct 01; 78(4):841-6. PubMed ID: 27586966
    [Abstract] [Full Text] [Related]

  • 6. Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma.
    Herman JM, Chang DT, Goodman KA, Dholakia AS, Raman SP, Hacker-Prietz A, Iacobuzio-Donahue CA, Griffith ME, Pawlik TM, Pai JS, O'Reilly E, Fisher GA, Wild AT, Rosati LM, Zheng L, Wolfgang CL, Laheru DA, Columbo LA, Sugar EA, Koong AC.
    Cancer; 2015 Apr 01; 121(7):1128-37. PubMed ID: 25538019
    [Abstract] [Full Text] [Related]

  • 7. Concomitant gemcitabine (Gemzar) and extended nodes irradiation in the treatment of pancreatic and biliary carcinoma: a phase I study.
    Morganti AG, Trodella L, Valentini V, Macchia G, Alfieri S, Smaniotto D, Luzi S, Costamagna G, Doglietto GB, Cellini N.
    Onkologie; 2003 Aug 01; 26(4):325-9. PubMed ID: 12972696
    [Abstract] [Full Text] [Related]

  • 8. Radiotherapy or Chemoradiation in Unresectable Biliary Cancer: A Retrospective Study.
    Bisello S, Buwenge M, Palloni A, Autorino R, Cellini F, Macchia G, Deodato F, Cilla S, Brandi G, Tagliaferri L, Cammelli S, Valentini V, Morganti AG, Mattiucci GC.
    Anticancer Res; 2019 Jun 01; 39(6):3095-3100. PubMed ID: 31177154
    [Abstract] [Full Text] [Related]

  • 9. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
    Franzese C, Bonu ML, Comito T, Clerici E, Loi M, Navarria P, Franceschini D, Pressiani T, Rimassa L, Scorsetti M.
    J Cancer Res Clin Oncol; 2020 Sep 01; 146(9):2289-2297. PubMed ID: 32524292
    [Abstract] [Full Text] [Related]

  • 10. Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma.
    Charoentum C, Thongprasert S, Chewaskulyong B, Munprakan S.
    World J Gastroenterol; 2007 May 28; 13(20):2852-4. PubMed ID: 17569122
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of systemic induction therapy in initially unresectable locally advanced intrahepatic and perihilar cholangiocarcinoma: A systematic review.
    Belkouz A, Nooijen LE, Riady H, Franken LC, van Oijen MGH, Punt CJA, Erdmann JI, Klümpen HJ.
    Cancer Treat Rev; 2020 Dec 28; 91():102110. PubMed ID: 33075684
    [Abstract] [Full Text] [Related]

  • 12. Protocol for the STRONG trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma, a phase I feasibility study.
    Koedijk MS, Heijmen BJM, Groot Koerkamp B, Eskens FALM, Sprengers D, Poley JW, van Gent DC, van der Laan LJW, van der Holt B, Willemssen FEJA, Méndez Romero A.
    BMJ Open; 2018 Oct 15; 8(10):e020731. PubMed ID: 30327398
    [Abstract] [Full Text] [Related]

  • 13. Klatskin tumor treated by inter-disciplinary therapies including stereotactic radiotherapy: a case report.
    Becker G, Momm F, Schwacha H, Hodapp N, Usadel H, Geissler M, Barke A, Schmitt-Gräff A, Henne K, Blum HE.
    World J Gastroenterol; 2005 Aug 21; 11(31):4923-6. PubMed ID: 16097074
    [Abstract] [Full Text] [Related]

  • 14. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
    Abdel-Rahman O, Elsayed Z, Elhalawani H.
    Cochrane Database Syst Rev; 2018 Apr 06; 4(4):CD011746. PubMed ID: 29624208
    [Abstract] [Full Text] [Related]

  • 15. Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer.
    Schellenberg D, Goodman KA, Lee F, Chang S, Kuo T, Ford JM, Fisher GA, Quon A, Desser TS, Norton J, Greco R, Yang GP, Koong AC.
    Int J Radiat Oncol Biol Phys; 2008 Nov 01; 72(3):678-86. PubMed ID: 18395362
    [Abstract] [Full Text] [Related]

  • 16. [Gemcitabine in the treatment of 4 patients with cholangiocarcinoma].
    Gallardo J, Cabrera E, Rubio B, González C, Cortés C.
    Rev Med Chil; 2001 Aug 01; 129(8):911-6. PubMed ID: 11680965
    [Abstract] [Full Text] [Related]

  • 17. [Conformal therapy of locally advanced cholangiocarcinoma of the main bile ducts].
    Bouras N, Caudry M, Saric J, Bonnel C, Rullier E, Trouette R, Demeaux H, Maire JP.
    Cancer Radiother; 2002 Feb 01; 6(1):22-9. PubMed ID: 11899677
    [Abstract] [Full Text] [Related]

  • 18. Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety.
    Gurka MK, Collins SP, Slack R, Tse G, Charabaty A, Ley L, Berzcel L, Lei S, Suy S, Haddad N, Jha R, Johnson CD, Jackson P, Marshall JL, Pishvaian MJ.
    Radiat Oncol; 2013 Mar 01; 8():44. PubMed ID: 23452509
    [Abstract] [Full Text] [Related]

  • 19. SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience.
    Tozzi A, Comito T, Alongi F, Navarria P, Iftode C, Mancosu P, Reggiori G, Clerici E, Rimassa L, Zerbi A, Fogliata A, Cozzi L, Tomatis S, Scorsetti M.
    Radiat Oncol; 2013 Jun 21; 8():148. PubMed ID: 23799996
    [Abstract] [Full Text] [Related]

  • 20. [A case of unresectable hilar bile duct cancer responding to chemo-radiotherapy by gemcitabine].
    Kohya N, Hashiguchi K, Yakabe T, Miyoshi A, Ohtsuka T, Kitahara K, Miyazaki K.
    Gan To Kagaku Ryoho; 2009 Oct 21; 36(10):1753-5. PubMed ID: 19838042
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.